Enoxaparin sodium biosimilar (Chandra Bhagat Pharma)
依诺肝素钠生物类似药 (Chandra Bhagat Pharma)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameEnoxaparin sodium biosimilar (Chandra Bhagat Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChandra Bhagat Pharma（Cbc）
China Registration ClassN/A
Develop Information
Active CompaniesChandra Bhagat Pharma（Cbc）
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A